HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel hemodynamic observation: worsening of tricuspid regurgitation with dobutamine infusion during a hemodynamic study.

Abstract
Dobutamine has been shown to improve right ventricular contractility and cardiac output in right ventricular failure. However, the effect of dobutamine in the select group of patients with severe tricuspid regurgitation (TR) has not been described previously. We report the case of a patient with severe TR and right heart failure who developed ventricularization of right atrial pressure after dobutamine infusion. This highlights the potential worsening of TR and right heart failure in patients with TR receiving dobutamine.
AuthorsElias B Hanna, Vijayendra Jaligam, D Luke Glancy
JournalThe Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society (J La State Med Soc) 2011 Nov-Dec Vol. 163 Issue 6 Pg. 325-7 ISSN: 0024-6921 [Print] United States
PMID22324092 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cardiotonic Agents
  • Dobutamine
Topics
  • Aged
  • Atrial Function, Right (drug effects)
  • Cardiotonic Agents (administration & dosage, adverse effects)
  • Dobutamine (administration & dosage, adverse effects)
  • Humans
  • Infusions, Intravenous
  • Male
  • Tricuspid Valve Insufficiency (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: